Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
CPEB1
|
ENSG00000214575.5 | cytoplasmic polyadenylation element binding protein 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
CPEB1 | hg19_v2_chr15_-_83240507_83240539 | -0.24 | 2.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_+_4385230 | 1.37 |
ENST00000536537.1
|
CCND2
|
cyclin D2 |
chr2_-_190044480 | 1.27 |
ENST00000374866.3
|
COL5A2
|
collagen, type V, alpha 2 |
chr9_+_105757590 | 1.09 |
ENST00000374798.3
ENST00000487798.1 |
CYLC2
|
cylicin, basic protein of sperm head cytoskeleton 2 |
chr13_-_20805109 | 1.08 |
ENST00000241124.6
|
GJB6
|
gap junction protein, beta 6, 30kDa |
chr16_-_56459354 | 1.06 |
ENST00000290649.5
|
AMFR
|
autocrine motility factor receptor, E3 ubiquitin protein ligase |
chr6_+_15401075 | 1.01 |
ENST00000541660.1
|
JARID2
|
jumonji, AT rich interactive domain 2 |
chr2_+_114256661 | 0.99 |
ENST00000306507.5
|
FOXD4L1
|
forkhead box D4-like 1 |
chr12_-_91539918 | 0.99 |
ENST00000548218.1
|
DCN
|
decorin |
chr4_-_74864386 | 0.96 |
ENST00000296027.4
|
CXCL5
|
chemokine (C-X-C motif) ligand 5 |
chr6_-_27114577 | 0.96 |
ENST00000356950.1
ENST00000396891.4 |
HIST1H2BK
|
histone cluster 1, H2bk |
chrX_-_107682702 | 0.94 |
ENST00000372216.4
|
COL4A6
|
collagen, type IV, alpha 6 |
chr20_-_10654639 | 0.94 |
ENST00000254958.5
|
JAG1
|
jagged 1 |
chr6_+_12290586 | 0.91 |
ENST00000379375.5
|
EDN1
|
endothelin 1 |
chr4_-_47983519 | 0.86 |
ENST00000358519.4
ENST00000544810.1 ENST00000402813.3 |
CNGA1
|
cyclic nucleotide gated channel alpha 1 |
chr12_-_52845910 | 0.85 |
ENST00000252252.3
|
KRT6B
|
keratin 6B |
chr8_-_57026541 | 0.84 |
ENST00000311923.1
|
MOS
|
v-mos Moloney murine sarcoma viral oncogene homolog |
chr18_-_31802056 | 0.82 |
ENST00000538587.1
|
NOL4
|
nucleolar protein 4 |
chr15_+_45406519 | 0.82 |
ENST00000323030.5
|
DUOXA2
|
dual oxidase maturation factor 2 |
chr14_-_75079026 | 0.78 |
ENST00000261978.4
|
LTBP2
|
latent transforming growth factor beta binding protein 2 |
chr12_-_52715179 | 0.77 |
ENST00000293670.3
|
KRT83
|
keratin 83 |
chr18_+_34124507 | 0.77 |
ENST00000591635.1
|
FHOD3
|
formin homology 2 domain containing 3 |
chr11_-_102826434 | 0.76 |
ENST00000340273.4
ENST00000260302.3 |
MMP13
|
matrix metallopeptidase 13 (collagenase 3) |
chr17_-_39553844 | 0.75 |
ENST00000251645.2
|
KRT31
|
keratin 31 |
chr18_-_31628558 | 0.75 |
ENST00000535384.1
|
NOL4
|
nucleolar protein 4 |
chr14_+_79745746 | 0.75 |
ENST00000281127.7
|
NRXN3
|
neurexin 3 |
chr17_-_76220740 | 0.74 |
ENST00000600484.1
|
AC087645.1
|
Uncharacterized protein |
chr13_-_103719196 | 0.72 |
ENST00000245312.3
|
SLC10A2
|
solute carrier family 10 (sodium/bile acid cotransporter), member 2 |
chr10_-_105845674 | 0.70 |
ENST00000353479.5
ENST00000369733.3 |
COL17A1
|
collagen, type XVII, alpha 1 |
chr3_+_99357319 | 0.68 |
ENST00000452013.1
ENST00000261037.3 ENST00000273342.4 |
COL8A1
|
collagen, type VIII, alpha 1 |
chr2_-_2334888 | 0.67 |
ENST00000428368.2
ENST00000399161.2 |
MYT1L
|
myelin transcription factor 1-like |
chr15_-_56209306 | 0.66 |
ENST00000506154.1
ENST00000338963.2 ENST00000508342.1 |
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
chr8_+_85095769 | 0.65 |
ENST00000518566.1
|
RALYL
|
RALY RNA binding protein-like |
chr3_+_101546827 | 0.65 |
ENST00000461724.1
ENST00000483180.1 ENST00000394054.2 |
NFKBIZ
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta |
chr8_+_85095497 | 0.64 |
ENST00000522455.1
ENST00000521695.1 |
RALYL
|
RALY RNA binding protein-like |
chr1_-_156675535 | 0.64 |
ENST00000368221.1
|
CRABP2
|
cellular retinoic acid binding protein 2 |
chr1_+_84630053 | 0.63 |
ENST00000394838.2
ENST00000370682.3 ENST00000432111.1 |
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chr12_-_122240792 | 0.62 |
ENST00000545885.1
ENST00000542933.1 ENST00000428029.2 ENST00000541694.1 ENST00000536662.1 ENST00000535643.1 ENST00000541657.1 |
AC084018.1
RHOF
|
AC084018.1 ras homolog family member F (in filopodia) |
chr4_-_116034979 | 0.61 |
ENST00000264363.2
|
NDST4
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 4 |
chr6_+_15246501 | 0.61 |
ENST00000341776.2
|
JARID2
|
jumonji, AT rich interactive domain 2 |
chr1_+_84630645 | 0.60 |
ENST00000394839.2
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chr1_+_209848749 | 0.60 |
ENST00000367029.4
|
G0S2
|
G0/G1switch 2 |
chr12_-_91572278 | 0.60 |
ENST00000425043.1
ENST00000420120.2 ENST00000441303.2 ENST00000456569.2 |
DCN
|
decorin |
chr14_+_75746340 | 0.59 |
ENST00000555686.1
ENST00000555672.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr8_+_77593448 | 0.58 |
ENST00000521891.2
|
ZFHX4
|
zinc finger homeobox 4 |
chr19_+_35634146 | 0.58 |
ENST00000586063.1
ENST00000270310.2 ENST00000588265.1 |
FXYD7
|
FXYD domain containing ion transport regulator 7 |
chr11_-_102651343 | 0.58 |
ENST00000279441.4
ENST00000539681.1 |
MMP10
|
matrix metallopeptidase 10 (stromelysin 2) |
chr9_+_70917276 | 0.58 |
ENST00000342833.2
|
FOXD4L3
|
forkhead box D4-like 3 |
chr12_-_123201337 | 0.57 |
ENST00000528880.2
|
HCAR3
|
hydroxycarboxylic acid receptor 3 |
chr20_-_46415341 | 0.56 |
ENST00000484875.1
ENST00000361612.4 |
SULF2
|
sulfatase 2 |
chr17_-_76921459 | 0.56 |
ENST00000262768.7
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
chr11_+_35160709 | 0.55 |
ENST00000415148.2
ENST00000433354.2 ENST00000449691.2 ENST00000437706.2 ENST00000360158.4 ENST00000428726.2 ENST00000526669.2 ENST00000433892.2 ENST00000278386.6 ENST00000434472.2 ENST00000352818.4 ENST00000442151.2 |
CD44
|
CD44 molecule (Indian blood group) |
chr18_+_29027696 | 0.54 |
ENST00000257189.4
|
DSG3
|
desmoglein 3 |
chr12_-_92536433 | 0.54 |
ENST00000551563.2
ENST00000546975.1 ENST00000549802.1 |
C12orf79
|
chromosome 12 open reading frame 79 |
chr4_-_52883786 | 0.54 |
ENST00000343457.3
|
LRRC66
|
leucine rich repeat containing 66 |
chr12_-_81763184 | 0.54 |
ENST00000548670.1
ENST00000541570.2 ENST00000553058.1 |
PPFIA2
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
chr4_-_74904398 | 0.54 |
ENST00000296026.4
|
CXCL3
|
chemokine (C-X-C motif) ligand 3 |
chr7_+_129984630 | 0.54 |
ENST00000355388.3
ENST00000497503.1 ENST00000463587.1 ENST00000461828.1 ENST00000494311.1 ENST00000466363.2 ENST00000485477.1 ENST00000431780.2 ENST00000474905.1 |
CPA5
|
carboxypeptidase A5 |
chr7_-_27205136 | 0.53 |
ENST00000396345.1
ENST00000343483.6 |
HOXA9
|
homeobox A9 |
chr20_-_46415297 | 0.53 |
ENST00000467815.1
ENST00000359930.4 |
SULF2
|
sulfatase 2 |
chrX_+_100805496 | 0.53 |
ENST00000372829.3
|
ARMCX1
|
armadillo repeat containing, X-linked 1 |
chr14_+_79745682 | 0.52 |
ENST00000557594.1
|
NRXN3
|
neurexin 3 |
chr12_-_96184533 | 0.52 |
ENST00000343702.4
ENST00000344911.4 |
NTN4
|
netrin 4 |
chr12_-_52779433 | 0.51 |
ENST00000257951.3
|
KRT84
|
keratin 84 |
chr5_-_147162263 | 0.51 |
ENST00000333010.6
ENST00000265272.5 |
JAKMIP2
|
janus kinase and microtubule interacting protein 2 |
chr1_-_156675368 | 0.51 |
ENST00000368222.3
|
CRABP2
|
cellular retinoic acid binding protein 2 |
chr18_-_31802282 | 0.50 |
ENST00000535475.1
|
NOL4
|
nucleolar protein 4 |
chr9_-_118417 | 0.50 |
ENST00000382500.2
|
FOXD4
|
forkhead box D4 |
chr20_+_16729003 | 0.49 |
ENST00000246081.2
|
OTOR
|
otoraplin |
chr2_+_105050794 | 0.48 |
ENST00000429464.1
ENST00000414442.1 ENST00000447380.1 |
AC013402.2
|
long intergenic non-protein coding RNA 1102 |
chr8_+_70378852 | 0.48 |
ENST00000525061.1
ENST00000458141.2 ENST00000260128.4 |
SULF1
|
sulfatase 1 |
chr2_+_210444748 | 0.48 |
ENST00000392194.1
|
MAP2
|
microtubule-associated protein 2 |
chr1_+_26485511 | 0.48 |
ENST00000374268.3
|
FAM110D
|
family with sequence similarity 110, member D |
chr17_-_15244894 | 0.47 |
ENST00000338696.2
ENST00000543896.1 ENST00000539245.1 ENST00000539316.1 ENST00000395930.1 |
TEKT3
|
tektin 3 |
chr12_-_81763127 | 0.47 |
ENST00000541017.1
|
PPFIA2
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
chr14_-_57277163 | 0.47 |
ENST00000555006.1
|
OTX2
|
orthodenticle homeobox 2 |
chr12_+_41221794 | 0.47 |
ENST00000547849.1
|
CNTN1
|
contactin 1 |
chr18_-_35145728 | 0.46 |
ENST00000361795.5
ENST00000603232.1 |
CELF4
|
CUGBP, Elav-like family member 4 |
chr7_-_20826504 | 0.46 |
ENST00000418710.2
ENST00000361443.4 |
SP8
|
Sp8 transcription factor |
chr9_+_116263778 | 0.45 |
ENST00000394646.3
|
RGS3
|
regulator of G-protein signaling 3 |
chr9_+_5450503 | 0.45 |
ENST00000381573.4
ENST00000381577.3 |
CD274
|
CD274 molecule |
chr9_-_21482312 | 0.45 |
ENST00000448696.3
|
IFNE
|
interferon, epsilon |
chr17_-_39197699 | 0.44 |
ENST00000306271.4
|
KRTAP1-1
|
keratin associated protein 1-1 |
chr1_-_167059830 | 0.43 |
ENST00000367868.3
|
GPA33
|
glycoprotein A33 (transmembrane) |
chr4_-_111119804 | 0.43 |
ENST00000394607.3
ENST00000302274.3 |
ELOVL6
|
ELOVL fatty acid elongase 6 |
chr5_-_115910630 | 0.43 |
ENST00000343348.6
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
chr8_+_77593474 | 0.43 |
ENST00000455469.2
ENST00000050961.6 |
ZFHX4
|
zinc finger homeobox 4 |
chr3_-_141747439 | 0.43 |
ENST00000467667.1
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
chr11_+_69924397 | 0.42 |
ENST00000355303.5
|
ANO1
|
anoctamin 1, calcium activated chloride channel |
chr3_-_108248169 | 0.42 |
ENST00000273353.3
|
MYH15
|
myosin, heavy chain 15 |
chr9_+_116263639 | 0.42 |
ENST00000343817.5
|
RGS3
|
regulator of G-protein signaling 3 |
chr9_+_42717234 | 0.42 |
ENST00000377590.1
|
FOXD4L2
|
forkhead box D4-like 2 |
chrX_+_117957741 | 0.41 |
ENST00000310164.2
|
ZCCHC12
|
zinc finger, CCHC domain containing 12 |
chr2_-_228244013 | 0.41 |
ENST00000304568.3
|
TM4SF20
|
transmembrane 4 L six family member 20 |
chr4_-_65275162 | 0.41 |
ENST00000381210.3
ENST00000507440.1 |
TECRL
|
trans-2,3-enoyl-CoA reductase-like |
chr11_+_69924639 | 0.41 |
ENST00000538023.1
ENST00000398543.2 |
ANO1
|
anoctamin 1, calcium activated chloride channel |
chrX_+_135278908 | 0.41 |
ENST00000539015.1
ENST00000370683.1 |
FHL1
|
four and a half LIM domains 1 |
chr20_+_58251716 | 0.41 |
ENST00000355648.4
|
PHACTR3
|
phosphatase and actin regulator 3 |
chr1_+_214161854 | 0.40 |
ENST00000435016.1
|
PROX1
|
prospero homeobox 1 |
chr5_-_141704566 | 0.40 |
ENST00000344120.4
ENST00000434127.2 |
SPRY4
|
sprouty homolog 4 (Drosophila) |
chr3_-_54962100 | 0.40 |
ENST00000273286.5
|
LRTM1
|
leucine-rich repeats and transmembrane domains 1 |
chr14_+_22309368 | 0.38 |
ENST00000390433.1
|
TRAV12-1
|
T cell receptor alpha variable 12-1 |
chr11_-_102714534 | 0.38 |
ENST00000299855.5
|
MMP3
|
matrix metallopeptidase 3 (stromelysin 1, progelatinase) |
chr6_+_31683117 | 0.38 |
ENST00000375825.3
ENST00000375824.1 |
LY6G6D
|
lymphocyte antigen 6 complex, locus G6D |
chr18_+_22040620 | 0.37 |
ENST00000426880.2
|
HRH4
|
histamine receptor H4 |
chr16_+_11439286 | 0.37 |
ENST00000312499.5
ENST00000576027.1 |
RMI2
|
RecQ mediated genome instability 2 |
chr5_-_27038683 | 0.37 |
ENST00000511822.1
ENST00000231021.4 |
CDH9
|
cadherin 9, type 2 (T1-cadherin) |
chr1_+_23037323 | 0.36 |
ENST00000544305.1
ENST00000374630.3 ENST00000400191.3 ENST00000374632.3 |
EPHB2
|
EPH receptor B2 |
chr20_+_58179582 | 0.36 |
ENST00000371015.1
ENST00000395639.4 |
PHACTR3
|
phosphatase and actin regulator 3 |
chr8_-_143999259 | 0.36 |
ENST00000323110.2
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2 |
chr17_-_36358166 | 0.36 |
ENST00000537432.1
|
TBC1D3
|
TBC1 domain family, member 3 |
chrX_+_135279179 | 0.35 |
ENST00000370676.3
|
FHL1
|
four and a half LIM domains 1 |
chr17_-_38911580 | 0.35 |
ENST00000312150.4
|
KRT25
|
keratin 25 |
chr1_-_200379129 | 0.35 |
ENST00000367353.1
|
ZNF281
|
zinc finger protein 281 |
chr19_-_58485895 | 0.35 |
ENST00000314391.3
|
C19orf18
|
chromosome 19 open reading frame 18 |
chr2_-_85645545 | 0.35 |
ENST00000409275.1
|
CAPG
|
capping protein (actin filament), gelsolin-like |
chr2_+_169757750 | 0.34 |
ENST00000375363.3
ENST00000429379.2 ENST00000421979.1 |
G6PC2
|
glucose-6-phosphatase, catalytic, 2 |
chr1_-_11907829 | 0.34 |
ENST00000376480.3
|
NPPA
|
natriuretic peptide A |
chr17_-_78450398 | 0.34 |
ENST00000306773.4
|
NPTX1
|
neuronal pentraxin I |
chr1_+_107683644 | 0.34 |
ENST00000370067.1
|
NTNG1
|
netrin G1 |
chr7_-_83824169 | 0.34 |
ENST00000265362.4
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
chr8_-_93029865 | 0.34 |
ENST00000422361.2
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr1_+_221051699 | 0.34 |
ENST00000366903.6
|
HLX
|
H2.0-like homeobox |
chr9_-_21995249 | 0.33 |
ENST00000494262.1
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
chr12_+_130646999 | 0.33 |
ENST00000539839.1
ENST00000229030.4 |
FZD10
|
frizzled family receptor 10 |
chr8_-_7681411 | 0.33 |
ENST00000334773.6
|
DEFB105A
|
defensin, beta 105A |
chr8_+_7345191 | 0.33 |
ENST00000335510.6
|
DEFB105B
|
defensin, beta 105B |
chr14_-_57277178 | 0.32 |
ENST00000339475.5
ENST00000554559.1 ENST00000555804.1 |
OTX2
|
orthodenticle homeobox 2 |
chr6_+_21593972 | 0.32 |
ENST00000244745.1
ENST00000543472.1 |
SOX4
|
SRY (sex determining region Y)-box 4 |
chr3_-_37216055 | 0.32 |
ENST00000336686.4
|
LRRFIP2
|
leucine rich repeat (in FLII) interacting protein 2 |
chr7_+_26591441 | 0.32 |
ENST00000420912.1
ENST00000457000.1 ENST00000430426.1 |
AC004947.2
|
AC004947.2 |
chr18_+_29769978 | 0.31 |
ENST00000269202.6
ENST00000581447.1 |
MEP1B
|
meprin A, beta |
chr4_-_41750922 | 0.31 |
ENST00000226382.2
|
PHOX2B
|
paired-like homeobox 2b |
chr11_-_57089671 | 0.31 |
ENST00000532437.1
|
TNKS1BP1
|
tankyrase 1 binding protein 1, 182kDa |
chr9_-_37034028 | 0.31 |
ENST00000520281.1
ENST00000446742.1 ENST00000522003.1 ENST00000523145.1 ENST00000414447.1 ENST00000377847.2 ENST00000377853.2 ENST00000377852.2 ENST00000523241.1 ENST00000520154.1 ENST00000358127.4 |
PAX5
|
paired box 5 |
chr17_+_73780852 | 0.31 |
ENST00000589666.1
|
UNK
|
unkempt family zinc finger |
chr2_+_173600514 | 0.31 |
ENST00000264111.6
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr17_-_39637392 | 0.31 |
ENST00000246639.2
ENST00000393989.1 |
KRT35
|
keratin 35 |
chr6_+_31105426 | 0.31 |
ENST00000547221.1
|
PSORS1C1
|
psoriasis susceptibility 1 candidate 1 |
chr6_+_41604747 | 0.30 |
ENST00000419164.1
ENST00000373051.2 |
MDFI
|
MyoD family inhibitor |
chr2_+_173600565 | 0.30 |
ENST00000397081.3
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr12_-_52967600 | 0.30 |
ENST00000549343.1
ENST00000305620.2 |
KRT74
|
keratin 74 |
chr15_-_55562479 | 0.30 |
ENST00000564609.1
|
RAB27A
|
RAB27A, member RAS oncogene family |
chr2_+_11679963 | 0.30 |
ENST00000263834.5
|
GREB1
|
growth regulation by estrogen in breast cancer 1 |
chr18_-_60985914 | 0.29 |
ENST00000589955.1
|
BCL2
|
B-cell CLL/lymphoma 2 |
chr7_-_81399411 | 0.29 |
ENST00000423064.2
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor) |
chr14_+_103058948 | 0.29 |
ENST00000262241.6
|
RCOR1
|
REST corepressor 1 |
chr1_-_32110467 | 0.29 |
ENST00000440872.2
ENST00000373703.4 |
PEF1
|
penta-EF-hand domain containing 1 |
chr6_+_114178512 | 0.29 |
ENST00000368635.4
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate |
chr10_+_133753533 | 0.29 |
ENST00000422256.2
|
PPP2R2D
|
protein phosphatase 2, regulatory subunit B, delta |
chr9_-_21995300 | 0.29 |
ENST00000498628.2
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
chr5_+_140071178 | 0.28 |
ENST00000508522.1
ENST00000448069.2 |
HARS2
|
histidyl-tRNA synthetase 2, mitochondrial |
chr2_+_192543153 | 0.28 |
ENST00000425611.2
|
NABP1
|
nucleic acid binding protein 1 |
chr3_-_155394152 | 0.28 |
ENST00000494598.1
|
PLCH1
|
phospholipase C, eta 1 |
chr4_-_76957214 | 0.28 |
ENST00000306621.3
|
CXCL11
|
chemokine (C-X-C motif) ligand 11 |
chr19_+_50191921 | 0.28 |
ENST00000420022.3
|
ADM5
|
adrenomedullin 5 (putative) |
chr17_-_39646116 | 0.27 |
ENST00000328119.6
|
KRT36
|
keratin 36 |
chr1_+_107683436 | 0.27 |
ENST00000370068.1
|
NTNG1
|
netrin G1 |
chr12_-_118797475 | 0.27 |
ENST00000541786.1
ENST00000419821.2 ENST00000541878.1 |
TAOK3
|
TAO kinase 3 |
chr2_-_80531399 | 0.27 |
ENST00000409148.1
ENST00000415098.1 ENST00000452811.1 |
LRRTM1
|
leucine rich repeat transmembrane neuronal 1 |
chr17_-_39580775 | 0.27 |
ENST00000225550.3
|
KRT37
|
keratin 37 |
chr2_+_173292390 | 0.27 |
ENST00000442250.1
ENST00000458358.1 ENST00000409080.1 |
ITGA6
|
integrin, alpha 6 |
chr15_-_55541227 | 0.27 |
ENST00000566877.1
|
RAB27A
|
RAB27A, member RAS oncogene family |
chr3_-_99595037 | 0.27 |
ENST00000383694.2
|
FILIP1L
|
filamin A interacting protein 1-like |
chr17_+_45286706 | 0.26 |
ENST00000393450.1
ENST00000572303.1 |
MYL4
|
myosin, light chain 4, alkali; atrial, embryonic |
chr10_+_17271266 | 0.26 |
ENST00000224237.5
|
VIM
|
vimentin |
chr17_+_7211656 | 0.26 |
ENST00000416016.2
|
EIF5A
|
eukaryotic translation initiation factor 5A |
chr18_+_3466248 | 0.26 |
ENST00000581029.1
ENST00000581442.1 ENST00000579007.1 |
RP11-838N2.4
|
RP11-838N2.4 |
chr6_-_130543958 | 0.26 |
ENST00000437477.2
ENST00000439090.2 |
SAMD3
|
sterile alpha motif domain containing 3 |
chr14_+_37126765 | 0.26 |
ENST00000402703.2
|
PAX9
|
paired box 9 |
chr21_+_17792672 | 0.26 |
ENST00000602620.1
|
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr7_+_134551583 | 0.26 |
ENST00000435928.1
|
CALD1
|
caldesmon 1 |
chr12_-_91451758 | 0.25 |
ENST00000266719.3
|
KERA
|
keratocan |
chrX_-_154299501 | 0.25 |
ENST00000369476.3
ENST00000369484.3 |
MTCP1
CMC4
|
mature T-cell proliferation 1 C-x(9)-C motif containing 4 |
chr11_-_11374904 | 0.25 |
ENST00000528848.2
|
CSNK2A3
|
casein kinase 2, alpha 3 polypeptide |
chr3_-_141747459 | 0.25 |
ENST00000477292.1
ENST00000478006.1 ENST00000495310.1 ENST00000486111.1 |
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
chr10_-_104262460 | 0.25 |
ENST00000446605.2
ENST00000369905.4 ENST00000545684.1 |
ACTR1A
|
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast) |
chr10_+_80008505 | 0.25 |
ENST00000434974.1
ENST00000423770.1 ENST00000432742.1 |
LINC00856
|
long intergenic non-protein coding RNA 856 |
chr3_+_40498783 | 0.25 |
ENST00000338970.6
ENST00000396203.2 ENST00000416518.1 |
RPL14
|
ribosomal protein L14 |
chr7_+_28452130 | 0.25 |
ENST00000357727.2
|
CREB5
|
cAMP responsive element binding protein 5 |
chr2_-_211168332 | 0.25 |
ENST00000341685.4
|
MYL1
|
myosin, light chain 1, alkali; skeletal, fast |
chr10_+_118305435 | 0.25 |
ENST00000369221.2
|
PNLIP
|
pancreatic lipase |
chr10_-_104262426 | 0.24 |
ENST00000487599.1
|
ACTR1A
|
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast) |
chr7_+_141811539 | 0.24 |
ENST00000550469.2
ENST00000477922.3 |
RP11-1220K2.2
|
Putative inactive maltase-glucoamylase-like protein LOC93432 |
chr4_+_74269956 | 0.24 |
ENST00000295897.4
ENST00000415165.2 ENST00000503124.1 ENST00000509063.1 ENST00000401494.3 |
ALB
|
albumin |
chr11_+_112832090 | 0.24 |
ENST00000533760.1
|
NCAM1
|
neural cell adhesion molecule 1 |
chr2_+_173292280 | 0.24 |
ENST00000264107.7
|
ITGA6
|
integrin, alpha 6 |
chr1_-_168513229 | 0.24 |
ENST00000367819.2
|
XCL2
|
chemokine (C motif) ligand 2 |
chr6_+_26124373 | 0.24 |
ENST00000377791.2
ENST00000602637.1 |
HIST1H2AC
|
histone cluster 1, H2ac |
chr13_+_22245522 | 0.24 |
ENST00000382353.5
|
FGF9
|
fibroblast growth factor 9 |
chr4_+_118955500 | 0.24 |
ENST00000296499.5
|
NDST3
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 |
chr18_-_33702078 | 0.24 |
ENST00000586829.1
|
SLC39A6
|
solute carrier family 39 (zinc transporter), member 6 |
chr20_+_30193083 | 0.23 |
ENST00000376112.3
ENST00000376105.3 |
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein |
chr7_+_39017504 | 0.23 |
ENST00000403058.1
|
POU6F2
|
POU class 6 homeobox 2 |
chr6_+_134758827 | 0.23 |
ENST00000431422.1
|
LINC01010
|
long intergenic non-protein coding RNA 1010 |
chr7_+_129906660 | 0.23 |
ENST00000222481.4
|
CPA2
|
carboxypeptidase A2 (pancreatic) |
chr1_-_200379104 | 0.23 |
ENST00000367352.3
|
ZNF281
|
zinc finger protein 281 |
chr1_+_116654376 | 0.23 |
ENST00000369500.3
|
MAB21L3
|
mab-21-like 3 (C. elegans) |
chr7_-_50860565 | 0.23 |
ENST00000403097.1
|
GRB10
|
growth factor receptor-bound protein 10 |
chr6_+_22146851 | 0.23 |
ENST00000606197.1
|
CASC15
|
cancer susceptibility candidate 15 (non-protein coding) |
chr4_+_144303093 | 0.23 |
ENST00000505913.1
|
GAB1
|
GRB2-associated binding protein 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.4 | 1.6 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.3 | 0.9 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.3 | 0.9 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.3 | 0.8 | GO:1901994 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.2 | 0.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.9 | GO:0097338 | response to clozapine(GO:0097338) |
0.1 | 0.5 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.1 | 0.4 | GO:2000979 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.1 | 0.6 | GO:0048880 | sensory system development(GO:0048880) |
0.1 | 0.4 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.1 | 0.7 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.1 | 0.2 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
0.1 | 1.7 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 0.6 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.1 | 0.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.8 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 1.0 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 0.8 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.1 | 0.4 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.1 | 0.8 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.3 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.1 | 1.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.7 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
0.1 | 1.0 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 1.5 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.1 | 1.0 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.2 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.1 | 0.3 | GO:0035905 | N-terminal peptidyl-lysine acetylation(GO:0018076) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.1 | 0.6 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.1 | 0.3 | GO:0043375 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
0.1 | 0.8 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.5 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 1.0 | GO:0035878 | nail development(GO:0035878) |
0.1 | 1.6 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.1 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
0.1 | 0.6 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.5 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 1.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.1 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.1 | 0.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.1 | 0.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.2 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
0.1 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.2 | GO:0036269 | swimming behavior(GO:0036269) |
0.1 | 0.2 | GO:1990637 | response to prolactin(GO:1990637) |
0.1 | 0.2 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.5 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.1 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.0 | 0.3 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.0 | 0.2 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.0 | 0.4 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.0 | 0.1 | GO:0071676 | negative regulation of mononuclear cell migration(GO:0071676) |
0.0 | 0.2 | GO:1903935 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
0.0 | 0.1 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.0 | 0.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.6 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.3 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.0 | 0.3 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.2 | GO:2000229 | pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) |
0.0 | 0.4 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.0 | 0.1 | GO:1901207 | regulation of heart looping(GO:1901207) |
0.0 | 0.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.3 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.0 | 0.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.2 | GO:0061056 | somite specification(GO:0001757) sclerotome development(GO:0061056) |
0.0 | 3.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.4 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 1.1 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.3 | GO:0021546 | rhombomere development(GO:0021546) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.3 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.0 | 0.4 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.0 | 0.2 | GO:0072014 | proximal tubule development(GO:0072014) |
0.0 | 0.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.9 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 0.1 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.0 | 0.1 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.0 | 4.1 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.0 | 0.1 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.1 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.0 | 0.8 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.3 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.3 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.0 | 0.2 | GO:0098704 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.0 | 0.5 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.0 | 0.1 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.0 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.9 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.2 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.1 | GO:1900157 | positive regulation of osteoclast proliferation(GO:0090290) regulation of bone mineralization involved in bone maturation(GO:1900157) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.0 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 1.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.1 | GO:1903978 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) regulation of microglial cell activation(GO:1903978) |
0.0 | 0.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.2 | GO:0003183 | mitral valve morphogenesis(GO:0003183) |
0.0 | 0.2 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.0 | 0.1 | GO:0015862 | uridine transport(GO:0015862) |
0.0 | 0.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.4 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.6 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.3 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.3 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.3 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.0 | 0.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.0 | 0.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.0 | 0.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.0 | 0.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.1 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.1 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.0 | 0.3 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.8 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.6 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.9 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.0 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.0 | 0.2 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 0.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.0 | 0.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.4 | GO:0000732 | strand displacement(GO:0000732) |
0.0 | 0.1 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.0 | 0.4 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.0 | 1.7 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.3 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.4 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.0 | GO:0060460 | subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) left lung development(GO:0060459) left lung morphogenesis(GO:0060460) superior vena cava morphogenesis(GO:0060578) |
0.0 | 0.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 0.7 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.4 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.3 | GO:0010458 | exit from mitosis(GO:0010458) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 1.1 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.2 | 0.9 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 1.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.2 | 1.8 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.2 | 0.5 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.1 | 1.7 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.5 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 0.5 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.1 | 0.6 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 0.3 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 1.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.5 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 0.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 1.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.2 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.0 | 1.1 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 2.1 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 2.8 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.4 | GO:0043219 | lateral loop(GO:0043219) |
0.0 | 0.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.3 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 2.1 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 1.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.3 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.2 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.0 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.1 | GO:1990037 | Lewy body core(GO:1990037) |
0.0 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.3 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.0 | 0.3 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.0 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.0 | 0.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.6 | GO:1990391 | DNA repair complex(GO:1990391) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.3 | 1.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 0.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 0.5 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
0.2 | 1.0 | GO:0042835 | BRE binding(GO:0042835) |
0.2 | 0.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.4 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.1 | 0.4 | GO:0004507 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.1 | 0.5 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.1 | 1.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.7 | GO:0050815 | phosphoserine binding(GO:0050815) phosphothreonine binding(GO:0050816) |
0.1 | 0.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 1.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 1.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.9 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.2 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.1 | 0.3 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 1.1 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.2 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.0 | 0.4 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 1.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.0 | 0.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.9 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 3.0 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.1 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.0 | 0.7 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.2 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.0 | 0.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.0 | 0.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.1 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.0 | 0.6 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.1 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.0 | 0.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 2.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.1 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.0 | 0.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.0 | 0.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.1 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.0 | 0.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 4.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 1.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 2.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 1.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 1.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 1.0 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.0 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 2.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 4.0 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 1.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 2.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 1.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 2.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 1.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 1.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |